Institutional Ownership
Gilead Sciences Inc
CUSIP 375558103COMGILDQ1 2026
Latest EPS (Diluted)
—
Q1 2026 · Mar 31, 2026
Latest Revenue
$6.96B
Reported quarter
Latest Net Income
$2.02B
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | — | — | $6.96B | $2.02B | 10-Q |
| Sep 30, 2025 | Q3 2025 | — | — | $7.77B | $3.05B | 10-Q |
| Jun 30, 2025 | Q2 2025 | — | — | $7.08B | $1.96B | 10-Q |
| Mar 31, 2025 | Q1 2025 | — | — | $6.67B | $1.31B | 10-Q |
| Sep 30, 2024 | Q3 2024 | — | — | $7.54B | $1.25B | 10-Q |
| Jun 30, 2024 | Q2 2024 | — | — | $6.95B | $1.61B | 10-Q |
| Mar 31, 2024 | Q1 2024 | — | — | $6.69B | -$4.17B | 10-Q |
| Sep 30, 2023 | Q3 2023 | — | — | $7.05B | $2.18B | 10-Q |
| Jun 30, 2023 | Q2 2023 | — | — | $6.60B | $1.04B | 10-Q |
| Mar 31, 2023 | Q1 2023 | — | — | $6.35B | $1.01B | 10-Q |
| Sep 30, 2022 | Q3 2022 | — | — | $7.04B | $1.79B | 10-Q |
| Jun 30, 2022 | Q2 2022 | — | — | $6.26B | $1.14B | 10-Q |